Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics - Wikidata - awgldk - TriplyDB

Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics

Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics

http://www.wikidata.org/entity/Q34253355

about

Pharmacometabolomics reveals racial differences in response to atenolol treatment Applications of metabolomics in cancer research Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine Metabolomics enables precision medicine: "A White Paper, Community Perspective"Harmonization and semantic annotation of data dictionaries from the Pharmacogenomics Research Network: a case study Integration of pharmacometabolomic and pharmacogenomic approaches reveals novel insights into antiplatelet therapy.Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology.Urine metabolomics in rats after administration of ketamine.Relating human genetic variation to variation in drug responses.Omics Screening for Pharmaceutical Efficacy and Safety in Clinical Practice Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo.Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine.TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics Pharmacometabolomics Informs Viromics toward Precision Medicine.Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines.A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks.Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics.Pharmacometabonomics and personalized medicine.Pharmacometabonomics in humans: a new tool for personalized medicine.Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.Environmental influences in the etiology of colorectal cancer: the premise of metabolomics.The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback.Klotho Gene and Selective Serotonin Reuptake Inhibitors: Response to Treatment in Late-Life Major Depressive Disorder.Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment.Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate

P2860

Q21559685-B78FD3E1-6E1C-4FD0-82D1-844896C5CB02 Q24600728-384ADB8D-8B5A-465F-AAE2-C8B0962695DD Q26748481-75E5CE7C-3FCD-4780-AD09-16D46021C64C Q26797273-3EBCB822-60ED-4A28-A047-7C369E1A0179 Q28067029-74BEA879-598B-4079-9707-80AA5954CF38 Q28831476-B263FF6C-A6F7-4B12-9B05-4BC7CB464FD2 Q30579651-BEDFF5B9-58F3-4F59-83ED-B10290CDD43B Q33974869-6F773577-8A87-4413-984F-1EA2C782614E Q35032056-22B69F9A-5D17-4789-AB01-F9106CD464C7 Q35067833-783AAA87-2DD7-4454-9D8B-AC9789E5E00C Q36252524-5EDA0715-3889-419D-BEAB-4102EE3BA815 Q36477760-7D972456-5493-4039-96EF-3E0EBB7BB095 Q36593835-BDAEB9C6-24B3-4CF7-91A3-C385AD8568C6 Q37078812-74ACCE39-9630-49CC-A1C8-946F879FA444 Q37213132-24A9EEE3-DD4D-4EAA-B67D-ED7929D3183D Q37368628-05EDEB35-8F50-431E-AC2D-C2B319C3BAEC Q37595491-D0F9F552-652D-4A6E-A064-6772EB28DE9D Q37686306-5C83DDBD-45DA-45F3-B0DF-08D8EE6DB6C3 Q37726989-D4272CEE-E794-46E8-8500-3F0F2620D597 Q38124254-A2FF07C4-7292-44AE-9BFB-6CD4DCA9808E Q38452107-E3F59CE8-46FD-4998-81D6-04C792B83C6C Q38657429-56674D23-7534-495C-A4B4-F1D7C379403E Q39392886-89FCF4F9-06FA-4DC7-B532-E2F4D562D3F0 Q41687556-7FA15C6A-0A45-4585-B7A9-70775BA0BDE5 Q48064738-5D7FE48D-D722-4D7D-8D23-67AF5710C704 Q48086902-E575FFC3-15CC-4681-8A61-8537976AC30B Q49332592-026AE3C3-4626-42EF-993E-7CC7747191B9 Q57112884-D68FC7C8-FAA8-4E45-98F0-80897211F335

P2860

Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics

http://www.wikidata.org/entity/Q34253355

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Merging pharmacometabolomics w ...... itor response pharmacogenomics

@ast

Merging pharmacometabolomics w ...... itor response pharmacogenomics

@en

Merging pharmacometabolomics w ...... itor response pharmacogenomics

@nl

type

label

Merging pharmacometabolomics w ...... itor response pharmacogenomics

@ast

Merging pharmacometabolomics w ...... itor response pharmacogenomics

@en

Merging pharmacometabolomics w ...... itor response pharmacogenomics

@nl

prefLabel

Merging pharmacometabolomics w ...... itor response pharmacogenomics

@ast

Merging pharmacometabolomics w ...... itor response pharmacogenomics

@en

Merging pharmacometabolomics w ...... itor response pharmacogenomics

@nl

P1433

Q34253355-35421CB0-CA47-4257-BCB5-05175BF76F77

P1476

Q34253355-F6B62D02-25FA-416B-92B6-A00C444EA016

P2093

Q34253355-01AB5116-08B5-4DB6-B6F0-14E4A324A78E

Q34253355-334C2B30-22B4-4BA4-A924-36B4E749C53D

Q34253355-42959FA9-6BC4-477A-B33D-C4490273F7DB

Q34253355-5205C2B6-53BE-419A-B86D-612E089F8C62

Q34253355-520762A7-F165-4340-9F32-C03136FBD44F

Q34253355-523005A0-09F2-4B41-A8D4-97D53417B070

Q34253355-56E9ABA4-309B-4C51-9612-ABD82F39F385

Q34253355-66323F8C-42F5-4593-B2BD-056CF029846E

Q34253355-67A009BD-9E17-4E44-B1F5-F1A0D5BBC029

Q34253355-813504E0-4822-4971-906D-785003B5F280

P2860

Q34253355-0BEFFC84-8C2B-4088-9425-3E3882724D3C

Q34253355-49FBB01E-1576-4239-9F5E-250C86814FAA

Q34253355-4E6E3061-8A47-4AA1-954B-1BF19415B3E5

Q34253355-6B137F02-7ECE-4E0B-B7F5-404FE46F0E57

Q34253355-83AA4DDA-BF35-4AD4-8A69-D0BED4A56C1E

Q34253355-A7A56D45-DB35-4534-B757-5F63ADAA70C4

Q34253355-B2DF6B67-A126-4EEB-95D3-42577BA9B082

Q34253355-B3E421C7-0C02-47F5-9B23-031FEE5CED1E

Q34253355-C539CC2C-4A1E-4E7E-BB32-47D5954F49A7

Q34253355-DBF9BB9D-F01A-49BE-936B-602A254B9535

P304

Q34253355-870C4DDC-01BA-4356-BFAF-1B8393DF4CCF

P31

Q34253355-1801C845-549E-41B9-89D4-278618DAE37E

P356

Q34253355-B516273F-EA3A-406C-8CD9-34908961AEFC

P433

Q34253355-DC79D51A-297D-4AF0-83C2-DFA21AB527FE

P478

Q34253355-22D029B8-C771-4595-8518-A74A2055028E

P50

Q34253355-2D0902E7-381B-4B4A-BBE5-00AC344EF136

Q34253355-2DD00164-0AB6-46F6-8DBC-C49AE0DEB822

Q34253355-36DBC4BF-3074-41B4-81F3-BA9EC6F9530E

Q34253355-851B3C13-3C15-4A7F-9230-BD0043592218

P577

Q34253355-4613316F-157C-4E57-A562-19967824C641

P698

Q34253355-5FD5E4BA-0634-4AB8-AB6E-D10EBF896F3E

P921

Q34253355-1EF7D709-16BF-4D32-8FF3-96DD674EBE7D

Q34253355-E7DB527F-83EA-46C8-85B4-79318DE45DF6

Q34253355-cce565e0-c403-485b-b0b7-468cdc0d34f0

P932

Q34253355-36F3F14B-1097-4C87-90DE-3DB058A73189

P356

FPC.0B013E32835001C9

P1433

Pharmacogenetics and Genomics

P1476

Merging pharmacometabolomics w ...... itor response pharmacogenomics

@en

P2093

Brooke Fridley

http://www.w3.org/2001/XMLSchema#string

Daniel Schaid

http://www.w3.org/2001/XMLSchema#string

David A Mrazek

http://www.w3.org/2001/XMLSchema#string

Gregory D Jenkins

http://www.w3.org/2001/XMLSchema#string

Hongjie Zhu

http://www.w3.org/2001/XMLSchema#string

Joanna Biernacka

http://www.w3.org/2001/XMLSchema#string

Karen Snyder

http://www.w3.org/2001/XMLSchema#string

Maureen Drews

http://www.w3.org/2001/XMLSchema#string

Michiaki Kubo

http://www.w3.org/2001/XMLSchema#string

Naoyuki Kamatani

http://www.w3.org/2001/XMLSchema#string

P2860

Inference of population structure using multilocus genotype data

A map of human genome variation from population-scale sequencing

MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes

Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations

Principal components analysis corrects for stratification in genome-wide association studies

Assessment of genotype imputation methods

Unifying candidate gene and GWAS Approaches in Asthma

Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.

Metabolomics: a global biochemical approach to drug response and disease.

A comprehensive evaluation of SNP genotype imputation.

P304

247-253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/FPC.0B013E32835001C9

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Rima Kaddurah-Daouk

Richard Weinshilboum

Anthony Batzler

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22322242

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

single-nucleotide polymorphism

P932

3303952

http://www.w3.org/2001/XMLSchema#string